Skip to main content
. 2022 Feb 1;12:783197. doi: 10.3389/fonc.2022.783197

Figure 1.

Figure 1

Efficacy of anti-PD-1 treatment according to the changes in inflammatory markers in AGC patients in the CR group (A–E), PR group (F–J), SD group (K–O), and PD group (P–T).